{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:03:31Z","timestamp":1790964211909,"version":"4.1.0"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"John Turner Cancer Research Funds"},{"name":"Australian Postgraduate Award"},{"name":"Victorian State Government Operational Infrastructure Support"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.semcancer.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T13:53:29Z","timestamp":1539266009000},"page":"265-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"special_numbering":"C","title":["Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells"],"prefix":"10.1016","volume":"53","author":[{"given":"Nuzhat","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Escalona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilys","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kannourakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2018.10.002_bib0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/B978-0-12-416618-9.00003-0","article-title":"Regulation of cancer metabolism by oncogenes and tumor suppressors","volume":"542","author":"Iurlaro","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fonc.2018.00117","article-title":"Influence of the tumor microenvironment on cancer cells metabolic reprogramming","volume":"8","author":"Gouirand","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-3701-3-9","article-title":"The regulation of cellular metabolism by tumor suppressor p53","volume":"3","author":"Liang","year":"2013","journal-title":"Cell Biosci."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122074","article-title":"p53 as a regulator of lipid metabolism in cancer","volume":"17","author":"Parrales","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0035","first-page":"5221","article-title":"MMAC1\/PTEN mutations in primary tumor specimens and tumor cell lines","volume":"57","author":"Teng","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1073\/pnas.96.4.1563","article-title":"Mutation of Pten\/Mmac1 in mice causes neoplasia in multiple organ systems","volume":"96","author":"Podsypanina","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0045","first-page":"3605","article-title":"High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+\/- mice","volume":"60","author":"Stambolic","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0050","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cmet.2014.03.023","article-title":"PTENalpha, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism","volume":"19","author":"Liang","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1080\/15548627.2018.1489477","article-title":"PTENalpha regulates mitophagy and maintains mitochondrial quality control","volume":"14","author":"Yin","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014241","article-title":"MYC activation is a hallmark of cancer initiation and maintenance","volume":"4","author":"Gabay","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0070","doi-asserted-by":"crossref","first-page":"36267","DOI":"10.1074\/jbc.M110.141606","article-title":"Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry","volume":"285","author":"Morrish","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0075","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","article-title":"Metabolic dependencies in RAS-driven cancers","volume":"21","author":"Kimmelman","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0080","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0085","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1073\/pnas.1307237110","article-title":"Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids","volume":"110","author":"Kamphorst","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0090","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0095","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2741\/3951","article-title":"Mechanisms of cancer-associated glycosylation changes","volume":"17","author":"Dall\u2019Olio","year":"2012","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0100","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.4161\/cc.25307","article-title":"Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance","volume":"12","author":"Lyssiotis","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cels.2018.06.003","article-title":"Four key steps control glycolytic flux in mammalian cells","volume":"7","author":"Tanner","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0110","first-page":"5522","article-title":"Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma","volume":"56","author":"Kimura","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.4218","article-title":"Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?","volume":"230","author":"Choi","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0120","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0130","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.celrep.2016.04.029","article-title":"Metabolic symbiosis enables adaptive resistance to anti-angiogenic therapy that is dependent on mTOR signaling","volume":"15","author":"Allen","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0135","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmet.2012.05.001","article-title":"Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo","volume":"15","author":"Marin-Valencia","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0140","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1158\/0008-5472.CAN-13-2893-T","article-title":"Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization","volume":"74","author":"Lim","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2009.358","article-title":"Q\u2019s next: the diverse functions of glutamine in metabolism, cell biology and cancer","volume":"29","author":"DeBerardinis","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","article-title":"Co-evolution of tumor cells and their microenvironment","volume":"25","author":"Polyak","year":"2009","journal-title":"Trends Genet."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0160","first-page":"387","article-title":"Fibroblast cooperation in the graft of tumor cells in nude mice","volume":"298","author":"Picard","year":"1984","journal-title":"C. R. Acad. Sci. III"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0165","first-page":"3290","article-title":"Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases","volume":"46","author":"Picard","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0170","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/1541-7786.MCR-12-0307","article-title":"Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue","volume":"10","author":"Karagiannis","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/path.4103","article-title":"From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation","volume":"229","author":"Servais","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0180","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.1620164114","article-title":"Stromal cues regulate the pancreatic cancer epigenome and metabolome","volume":"114","author":"Sherman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-10-2743","article-title":"Regulation of cancer stem cells by cytokine networks: attacking cancer\u2019s inflammatory roots","volume":"17","author":"Korkaya","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0190","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4161\/cc.25695","article-title":"Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and \"fibroblast addiction\" are new therapeutic targets for drug discovery","volume":"12","author":"Lisanti","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4161\/cc.21384","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by TGF-beta drives tumor growth: connecting TGF-beta signaling with \"Warburg-like\" cancer metabolism and L-lactate production","volume":"11","author":"Guido","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ncb2432","article-title":"Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0205","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/bjc.2012.398","article-title":"Endothelial cell metabolism and implications for cancer therapy","volume":"107","author":"Harjes","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0210","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/joim.12016","article-title":"Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force","volume":"273","author":"Polet","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fimmu.2018.00353","article-title":"Targeting tumor metabolism: a new challenge to improve immunotherapy","volume":"9","author":"Kouidhi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18632\/oncoscience.390","article-title":"Coaching tumor-infiltrating CD8(+) T cells to eat right","volume":"5","author":"Kurupati","year":"2018","journal-title":"Oncoscience"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fimmu.2017.00248","article-title":"Metabolic hallmarks of tumor and immune cells in the tumor microenvironment","volume":"8","author":"Renner","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0230","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0235","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells","volume":"12","author":"Brandacher","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0240","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0245","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1189\/jlb.0508310","article-title":"Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages","volume":"85","author":"Choi","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ncb2717","article-title":"Cancer stem cells: the challenges ahead","volume":"15","author":"Medema","year":"2013","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0260","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","article-title":"The developing cancer stem-cell model: clinical challenges and opportunities","volume":"13","author":"Vermeulen","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0270","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/cdd.2008.20","article-title":"Cancer stem cells--old concepts, new insights","volume":"15","author":"Vermeulen","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0275","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0280","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1042\/BCJ20170164","article-title":"Cancer stem cells (CSCs): metabolic strategies for their identification and eradication","volume":"475","author":"De Francesco","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0285","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/biot.201100347","article-title":"Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives","volume":"7","author":"Bernhardt","year":"2012","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0290","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbrc.2009.02.156","article-title":"Embryonic stem cell markers expression in cancers","volume":"383","author":"Schoenhals","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12265-012-9431-2","article-title":"Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells","volume":"6","author":"Folmes","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0305","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.stem.2012.10.002","article-title":"Metabolic plasticity in stem cell homeostasis and differentiation","volume":"11","author":"Folmes","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0310","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0315","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.18632\/oncotarget.14196","article-title":"Targeting cancer stem cell propagation with palbociclib, a CDK4\/6 inhibitor: telomerase drives tumor cell heterogeneity","volume":"8","author":"Bonuccelli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0320","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0325","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","article-title":"Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0330","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1182\/blood-2007-05-087759","article-title":"A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche","volume":"110","author":"Jang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0335","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1084\/jem.20081297","article-title":"TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species","volume":"205","author":"Chen","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-016-0712-6","article-title":"Cancer stem cell metabolism","volume":"18","author":"Peiris-Pages","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0350","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","article-title":"Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer","volume":"23","author":"Dong","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0355","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4161\/15384101.2014.974419","article-title":"Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma","volume":"14","author":"Shen","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0360","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.18632\/oncotarget.2120","article-title":"Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine","volume":"5","author":"Isayev","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0365","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.bjc.6604794","article-title":"Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas","volume":"100","author":"Colomiere","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0370","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/Jak\/stat pathway in human malignancies","volume":"30","author":"Sansone","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0375","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/stem.185","article-title":"STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells","volume":"27","author":"Sherry","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0380","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI44745","article-title":"The JAK2\/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors","volume":"121","author":"Marotta","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0385","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/cdd.2011.77","article-title":"Absolute requirement for STAT3 function in small-intestine crypt stem cell survival","volume":"18","author":"Matthews","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0390","doi-asserted-by":"crossref","first-page":"823","DOI":"10.18632\/aging.100232","article-title":"A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction","volume":"2","author":"Demaria","year":"2010","journal-title":"Aging (Albany NY)."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2014.00075","article-title":"Targeted disruption of the JAK2\/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden","volume":"4","author":"Abubaker","year":"2014","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0400","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2407-14-317","article-title":"Inhibition of the JAK2\/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden","volume":"14","author":"Abubaker","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0405","doi-asserted-by":"crossref","first-page":"16599","DOI":"10.18632\/oncotarget.24615","article-title":"Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer","volume":"9","author":"Chan","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0410","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.18632\/oncotarget.4401","article-title":"Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells","volume":"6","author":"De Luca","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0415","doi-asserted-by":"crossref","first-page":"30472","DOI":"10.18632\/oncotarget.5401","article-title":"High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant","volume":"6","author":"Farnie","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0420","doi-asserted-by":"crossref","first-page":"37813","DOI":"10.1074\/jbc.M110.200675","article-title":"Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species","volume":"286","author":"Achuthan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0425","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1073\/pnas.1106704108","article-title":"Metabolic state of glioma stem cells and nontumorigenic cells","volume":"108","author":"Vlashi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0430","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.188292.112","article-title":"Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells","volume":"26","author":"Janiszewska","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0435","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells","volume":"22","author":"Sancho","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0440","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.2882","article-title":"A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance","volume":"18","author":"Ito","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0445","first-page":"594","article-title":"Superior T memory stem cell persistence supports long-lived T cell memory","volume":"123","author":"Lugli","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0450","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","article-title":"Fatty acid metabolism in the regulation of T cell function","volume":"36","author":"Lochner","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0455","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0460","doi-asserted-by":"crossref","first-page":"16805","DOI":"10.1073\/pnas.0904606106","article-title":"HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells","volume":"106","author":"Pietras","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0465","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer","volume":"129","author":"Keith","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0470","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ncb2048","article-title":"Wnt activity defines colon cancer stem cells and is regulated by the microenvironment","volume":"12","author":"Vermeulen","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0475","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cyto.b.20530","article-title":"Localization of CD44 and CD90 positive cells to the invasive front of breast tumors","volume":"78","author":"Donnenberg","year":"2010","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0480","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.4161\/cc.19679","article-title":"Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness","volume":"11","author":"Lonardo","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0485","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/bcj.2012.36","article-title":"Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms","volume":"2","author":"Kobune","year":"2012","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0490","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","article-title":"Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay","volume":"72","author":"Fiaschi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0495","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0500","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2016.11.003","article-title":"Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors","volume":"64","author":"Wu","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0505","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4161\/cbt.12.12.18671","article-title":"Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance","volume":"12","author":"Ko","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0510","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/stem.2076","article-title":"Brief report: human mesenchymal stem-like cells facilitate floating tumorigenic cell growth via glutamine-ammonium cycle","volume":"33","author":"Tang","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0515","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1101\/gad.225334.113","article-title":"Epithelial-mesenchymal plasticity in carcinoma metastasis","volume":"27","author":"Tsai","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0520","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3892\/ijo.2015.2874","article-title":"Dlx-2 is implicated in TGF-beta- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation","volume":"46","author":"Lee","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0525","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","article-title":"Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation","volume":"16","author":"Lee","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0530","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/MCB.00992-14","article-title":"WNT signaling: an emerging mediator of cancer cell metabolism?","volume":"35","author":"Sherwood","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0535","doi-asserted-by":"crossref","first-page":"15526","DOI":"10.1073\/pnas.1407717111","article-title":"Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition","volume":"111","author":"Hamabe","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0540","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","article-title":"Lactate: a metabolic key player in cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0545","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bbrc.2015.12.078","article-title":"LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer","volume":"469","author":"Jiang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0550","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/srep00785","article-title":"Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy","volume":"2","author":"Lin","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2049-3002-2-21","article-title":"Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism","volume":"2","author":"Aspuria","year":"2014","journal-title":"Cancer Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0560","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.18632\/oncotarget.6879","article-title":"Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0565","doi-asserted-by":"crossref","first-page":"55543","DOI":"10.18632\/oncotarget.10837","article-title":"A FASN-TGF-beta1-FASN regulatory loop contributes to high EMT\/metastatic potential of cisplatin-resistant non-small cell lung cancer","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0570","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cmet.2013.08.001","article-title":"Role of endothelial cell metabolism in vessel sprouting","volume":"18","author":"De Bock","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0575","doi-asserted-by":"crossref","first-page":"L513","DOI":"10.1152\/ajplung.00274.2009","article-title":"Critical role for lactate dehydrogenase A in aerobic glycolysis that sustains pulmonary microvascular endothelial cell proliferation","volume":"299","author":"Parra-Bonilla","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0580","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0585","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2049-3002-2-19","article-title":"Endothelial cell metabolism: parallels and divergences with cancer cell metabolism","volume":"2","author":"Verdegem","year":"2014","journal-title":"Cancer Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0590","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","article-title":"Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells","volume":"468","author":"Ricci-Vitiani","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0595","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09624","article-title":"Glioblastoma stem-like cells give rise to tumour endothelium","volume":"468","author":"Wang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0600","doi-asserted-by":"crossref","first-page":"41499","DOI":"10.1038\/srep41499","article-title":"CD133(+) cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0605","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1038\/onc.2014.257","article-title":"VEGF drives cancer-initiating stem cells through VEGFR-2\/Stat3 signaling to upregulate Myc and Sox2","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0610","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/stem.1793","article-title":"Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells","volume":"32","author":"Krishnamurthy","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0615","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1096\/fj.08-106468","article-title":"VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase","volume":"22","author":"Wright","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0620","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nature06613","article-title":"HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha","volume":"451","author":"Arany","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0625","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0630","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0635","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1947601909356574","article-title":"Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates","volume":"1","author":"Loges","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0640","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9720912","article-title":"New mechanisms of tumor-associated macrophages on promoting tumor progression: recent research advances and potential targets for tumor immunotherapy","volume":"2016","author":"Guo","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0645","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fonc.2018.00235","article-title":"Active role of the necrotic zone in desensitization of hypoxic macrophages and regulation of CSC-fate: a hypothesis","volume":"8","author":"Mehrabi","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0650","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fimmu.2017.00939","article-title":"Metabolic plasticity of stem cells and macrophages in cancer","volume":"8","author":"Krstic","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0655","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/08830185.2014.969421","article-title":"Cellular metabolism and macrophage functional polarization","volume":"34","author":"Zhu","year":"2015","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0665","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0670","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0675","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0680","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fimmu.2015.00602","article-title":"Macrophages during the fibrotic process: M2 as friend and foe","volume":"6","author":"Braga","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0685","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0690","first-page":"11","article-title":"Tumor-associated macrophages: effectors of angiogenesis and tumor progression","volume":"1796","author":"Coffelt","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0695","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0022034515599766","article-title":"Head and neck cancer stem cells: from identification to tumor immune network","volume":"94","author":"Dionne","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0700","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0705","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2005.02.007","article-title":"Cellular ligands of activating NK receptors","volume":"26","author":"Bottino","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0710","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jop.12320","article-title":"Prognostic implication of CD57, CD16, and TGF-beta expression in oral squamous cell carcinoma","volume":"45","author":"Taghavi","year":"2016","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0715","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.0802845","article-title":"NK cells recognize and kill human glioblastoma cells with stem cell-like properties","volume":"182","author":"Castriconi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0720","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","article-title":"Immunobiological characterization of cancer stem cells isolated from glioblastoma patients","volume":"16","author":"Di Tomaso","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0725","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1158\/0008-5472.CAN-08-3343","article-title":"Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells","volume":"69","author":"Santisteban","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0730","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-12-2432","article-title":"Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis","volume":"73","author":"Akalay","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0735","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1172\/JCI64057","article-title":"Nanog signaling in cancer promotes stem-like phenotype and immune evasion","volume":"122","author":"Noh","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0740","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10585-015-9717-2","article-title":"NANOG signaling promotes metastatic capability of immunoedited tumor cells","volume":"32","author":"Lee","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0745","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/ijc.30834","article-title":"PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K\/AKT pathway activation","volume":"141","author":"Almozyan","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"59","key":"10.1016\/j.semcancer.2018.10.002_bib0750","first-page":"225","article-title":"Cancer statistics","volume":"2009","author":"Jemal","year":"2009","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0755","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0760","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2006.03.011","article-title":"Systemic therapy for ovarian cancer: current status and new treatments","volume":"33","author":"Ozols","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0765","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0770","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.trecan.2016.12.005","article-title":"Tumor-host cell interactions in ovarian cancer: pathways to therapy failure","volume":"3","author":"Pogge von Strandmann","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0775","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0780","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcp.21240","article-title":"Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm","volume":"213","author":"Ahmed","year":"2007","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0785","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression","volume":"25","author":"Hudson","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046858","article-title":"Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors","volume":"7","author":"Latifi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0795","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1040-8428(00)00086-X","article-title":"Multicellular resistance: a paradigm for clinical resistance?","volume":"36","author":"Desoize","year":"2000","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0800","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0805","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0810","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/obr.12450","article-title":"Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression","volume":"17","author":"Chkourko Gusky","year":"2016","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0815","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0820","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s12015-011-9344-5","article-title":"Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches","volume":"8","author":"Aguilar-Gallardo","year":"2012","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0825","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcb.24317","article-title":"Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance","volume":"114","author":"Ahmed","year":"2013","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0830","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mam.2013.06.002","article-title":"Ovarian cancer stem cells: molecular concepts and relevance as therapeutic targets","volume":"39","author":"Ahmed","year":"2014","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0835","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2741\/3693","article-title":"Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer","volume":"16","author":"Curley","year":"2011","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0840","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0845","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1525-1438.2007.01056.x","article-title":"Expression of CD133-1 and CD133-2 in ovarian cancer","volume":"18","author":"Ferrandina","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0850","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0855","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0860","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0865","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029079","article-title":"Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer","volume":"7","author":"Vathipadiekal","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0870","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0875","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1073\/pnas.1005529108","article-title":"Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells","volume":"108","author":"Stewart","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0880","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3802\/jgo.2018.29.e32","article-title":"Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism","volume":"29","author":"Li","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0885","first-page":"519","article-title":"Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer","volume":"35","author":"Jin","year":"2014","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0890","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10238-013-0250-9","article-title":"Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer","volume":"14","author":"Suh","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0895","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.18632\/oncotarget.14910","article-title":"Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells","volume":"8","author":"Taylor","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0900","first-page":"6329","article-title":"PDK1 is expressed in ovarian serous carcinoma and correlates with improved survival in high-grade tumors","volume":"35","author":"Lohneis","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0905","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12032-014-0391-z","article-title":"Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer","volume":"32","author":"Cai","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0910","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12967-015-0511-3","article-title":"Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer","volume":"13","author":"Bauerschlag","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0915","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajpath.2013.04.023","article-title":"Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models","volume":"183","author":"Clark","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0920","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yexcr.2014.08.028","article-title":"Ovarian tumor-initiating cells display a flexible metabolism","volume":"328","author":"Anderson","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0925","first-page":"1357","article-title":"Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer","volume":"15","author":"Sato","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0930","article-title":"Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism","volume":"9","author":"Liao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0935","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.18632\/oncotarget.2010","article-title":"Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation","volume":"5","author":"Pasto","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2016.11.004","article-title":"Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells","volume":"20","author":"Li","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0945","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156800910791190175","article-title":"Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer","volume":"10","author":"Ahmed","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0950","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/jcb.23199","article-title":"Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile","volume":"112","author":"Latifi","year":"2011","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0955","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden","volume":"12","author":"Abubaker","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0960","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-015-0417-y","article-title":"A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer","volume":"14","author":"Samardzija","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0965","first-page":"e1006","article-title":"Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients","volume":"2","author":"Latifi","year":"2014","journal-title":"J. Cancer Stem Cell Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0970","doi-asserted-by":"crossref","first-page":"30016","DOI":"10.1038\/srep30061","article-title":"Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumour cells","volume":"6","author":"Ahmed","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0975","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2016.09.020","article-title":"Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab","volume":"384","author":"Luo","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0980","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.18632\/oncotarget.2059","article-title":"Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells","volume":"5","author":"Corominas-Faja","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jprot.2017.11.017","article-title":"Label-free quantitative proteomic profiling of colon cancer cells identifies acetyl-CoA carboxylase alpha as antitumor target of Citrus limon-derived nanovesicles","volume":"173","author":"Raimondo","year":"2018","journal-title":"J. Proteomics"},{"key":"10.1016\/j.semcancer.2018.10.002_bib0990","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/00365521.2016.1190399","article-title":"Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells","volume":"51","author":"Yu","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib0995","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/1541-7786.MCR-13-0576","article-title":"Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors","volume":"12","author":"Panosyan","year":"2014","journal-title":"Mol. Cancer Res ."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1000","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.jprot.2012.07.047","article-title":"Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells","volume":"75","author":"Lin","year":"2012","journal-title":"J. Proteomics"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1005","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3389\/fimmu.2017.01714","article-title":"Mevalonate metabolism in immuno-oncology","volume":"8","author":"Gruenbacher","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/1535370218760283","article-title":"SREBP2 contributes to cisplatin resistance in ovarian cancer cells","volume":"243","author":"Zheng","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201404-0714OC","article-title":"Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis","volume":"190","author":"Yang","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1020","doi-asserted-by":"crossref","first-page":"173907","DOI":"10.1155\/2010\/173907","article-title":"PRIC295, a nuclear receptor coactivator, identified from PPARalpha-interacting cofactor complex","volume":"2010","author":"Pyper","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1025","doi-asserted-by":"crossref","first-page":"27898","DOI":"10.1074\/jbc.M113.486696","article-title":"The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase","volume":"288","author":"Viswakarma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.molcel.2015.10.017","article-title":"NADP(+)-IDH mutations promote hypersuccinylation that impairs mitochondria respiration and induces apoptosis resistance","volume":"60","author":"Li","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1158\/0008-5472.CAN-17-1912","article-title":"SHMT2 desuccinylation by SIRT5 drives cancer cell proliferation","volume":"78","author":"Yang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1040","doi-asserted-by":"crossref","first-page":"e47567","DOI":"10.1371\/journal.pone.0047567","article-title":"Inhibiting delta-6 desaturase activity suppresses tumor growth in mice","volume":"7","author":"He","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/cas.12129","article-title":"Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue","volume":"104","author":"Pender-Cudlip","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.celrep.2016.09.045","article-title":"Addiction to coupling of the Warburg effect with glutamine catabolism in cancer cells","volume":"17","author":"Smith","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","article-title":"ATP citrate lyase inhibition can suppress tumor cell growth","volume":"8","author":"Hatzivassiliou","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1060","doi-asserted-by":"crossref","first-page":"43713","DOI":"10.18632\/oncotarget.9666","article-title":"Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism","volume":"7","author":"Shah","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1065","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1158\/1535-7163.MCT-13-0098","article-title":"ATP citrate lyase mediates resistance of colorectal cancer cells to SN38","volume":"12","author":"Zhou","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1070","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ajpath.2013.01.048","article-title":"Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact","volume":"182","author":"Migita","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1075","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1158\/2326-6066.CIR-14-0101","article-title":"Prognostic impact of human leukocyte antigen class I expression and association of platinum resistance with immunologic profiles in epithelial ovarian cancer","volume":"2","author":"Mariya","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature12653","article-title":"MX2 is an interferon-induced inhibitor of HIV-1 infection","volume":"502","author":"Kane","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1090","doi-asserted-by":"crossref","DOI":"10.1177\/1758834017749748","article-title":"Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients","volume":"10","author":"Karachaliou","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/jir.2012.0159","article-title":"A death-promoting role for ISG54\/IFIT2","volume":"33","author":"Reich","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1100","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.18632\/oncotarget.22122","article-title":"Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt\/beta-catenin signaling confers anti-apoptotic properties to colorectal cancer cells","volume":"8","author":"Ohsugi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2015.10.016","article-title":"Blocking TNF-alpha inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells","volume":"370","author":"Lai","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1110","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1158\/0008-5472.CAN-15-1885","article-title":"Agonist-mediated activation of STING induces apoptosis in malignant B cells","volume":"76","author":"Tang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1115","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1084\/jem.20161674","article-title":"Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes","volume":"214","author":"Cerboni","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1120","doi-asserted-by":"crossref","first-page":"e0165681","DOI":"10.1371\/journal.pone.0165681","article-title":"Decreased expression of TMEM173 predicts poor prognosis in patients with hepatocellular carcinoma","volume":"11","author":"Bu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2362.2007.01763.x","article-title":"Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate","volume":"37","author":"Patrikainen","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1130","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ajpath.2011.11.030","article-title":"Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer","volume":"180","author":"Sircar","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature25465","article-title":"Asparagine bioavailability governs metastasis in a model of breast cancer","volume":"554","author":"Knott","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1140","doi-asserted-by":"crossref","first-page":"18777","DOI":"10.1074\/jbc.M611763200","article-title":"Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation","volume":"282","author":"Brusselmans","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/pcan.2012.14","article-title":"Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer","volume":"15","author":"Fukuma","year":"2012","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/bbrc.1996.0265","article-title":"Regulation of fatty acid synthase expression by cholesterol in human cultured cells","volume":"219","author":"Kawabe","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1155","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","article-title":"Stearoyl-CoA desaturase promotes liver fibrosis and tumor development in mice via a Wnt positive-signaling loop by stabilization of low-density lipoprotein-receptor-related proteins 5 and 6","volume":"152","author":"Lai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40170-016-0146-8","article-title":"Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments","volume":"4","author":"Peck","year":"2016","journal-title":"Cancer Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1165","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/onc.2017.75","article-title":"Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP\/TAZ","volume":"36","author":"Noto","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2017.07.027","article-title":"Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells","volume":"406","author":"Pisanu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2010.12.015","article-title":"Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses","volume":"23","author":"Barber","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms19010273","article-title":"Different lipid regulation in ovarian cancer: inhibition of the immune system","volume":"19","author":"Wefers","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1185","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1471-0528.2004.00142.x","article-title":"Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer","volume":"111","author":"Santin","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1190","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1189\/jlb.0705395","article-title":"The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses","volume":"79","author":"Crespo","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1195","first-page":"113","article-title":"Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion","volume":"38","author":"Nonaka","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1200","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/cmi.2015.57","article-title":"Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment, Cell","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1205","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1210","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7729","article-title":"Oncogenic JAK2(V617F) causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms","volume":"10","author":"Prestipino","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1215","doi-asserted-by":"crossref","first-page":"e1001","DOI":"10.14343\/JCSCR.2015.3e1001","article-title":"Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics","volume":"3","author":"Abubaker","year":"2015","journal-title":"J. Cancer Stem Cell Res."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1220","doi-asserted-by":"crossref","DOI":"10.1186\/s40661-016-0033-6","article-title":"The role of immune checkpoint inhibition in the treatment of ovarian cancer","volume":"3","author":"Gaillard","year":"2016","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1225","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00151.2012","article-title":"Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration","volume":"303","author":"Caneba","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1230","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.18632\/oncotarget.14118","article-title":"Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells","volume":"8","author":"Pasto","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2018.10.002_bib1235","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1073\/pnas.0915086107","article-title":"Natural immunity to pluripotency antigen OCT4 in humans","volume":"107","author":"Dhodapkar","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2018.10.002_bib1240","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3389\/fimmu.2018.01412","article-title":"Immune curbing of cancer stem cells by CTLs directed to NANOG","volume":"9","author":"Wefers","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X1830049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X1830049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:34:11Z","timestamp":1760916851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X1830049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":248,"alternative-id":["S1044579X1830049X"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2018.10.002","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}